SOPHiA DDM™ Enhanced Clinical Exome Solution

A comprehensive solution combining a capture-based enrichment kit and the SOPHiA DDM™ platform for advanced clinical exome analysis, featuring targeted enhancements to increase coverage in critical regions and detect complex variants in a single workflow.

Detailed Description

Operating Principle

A genomic application integrating a capture enrichment kit with the advanced analytical modules of the SOPHiA DDM™ platform. The solution expands the SOPHiA DDM™ Clinical Exome Solution v3 kit with targeted probes to boost coverage in critical genomic regions and dedicated algorithms that reliably detect hard-to-identify variants, all within a single test.

SOPHiA Clinical Exome Solution

Clinical Applications

Specially designed to advance the study of rare and hereditary diseases, and to consolidate indications such as carrier screening and hereditary cancer into a unified workflow.

Benefits

Increases laboratory efficiency by consolidating multiple tests into one. Achieves sensitivities comparable to targeted panels in critical genomic regions. Reduces the complexity of genomic data interpretation with specific features through the use of dedicated software.

Intended Audience/User

Laboratories seeking an expanded clinical exome solution for multiple indications (rare/hereditary diseases, carrier screening, hereditary cancer) with advanced analytical capabilities and comprehensive support.

Key Features

Expanded coverage of the clinical exome + mitochondrial genome + ~200 relevant non-coding variants.
Specific enhancements for hereditary cancer (94 genes) and carrier screening (155 genes).
Reliable detection of complex variants: 1–2 exon CNVs, Alu insertions, gene conversions (PMS2/PMS2CL, SMN1/SMN2, CYP21A2), Boland inversions (MSH2), repetitive tracts (CFTR).
Proven analytical performance: SNV/Indel sensitivity 99.8%; precision 99.0%; >99% of on-target regions at >25×/>50× coverage.
Unified and efficient workflow with advanced interpretation tools: ACMG scoring, virtual panel generation, duo and trio analysis, and reporting.
Direct integration capabilities with Alamut™ Visual Plus.
Access to the SOPHiA Genetics community to securely and anonymously share knowledge among specialists.
Expert support and cloud storage: secure, unlimited storage following industrial encryption standards and restricted access control to empower the interpretation of challenging variants.

Area:

Exomes, Hereditary and/or Rare Diseases, Molecular Genetics
Consult our experts

Google reCaptcha: Invalid site key.

Related products

1928 Platform

Cloud-based bioinformatics platform for the standardized and automated analysis of microbiology sequencing data, complemented by hospital genomic surveillance to detect, track, and prevent infections and antimicrobial resistance (AMR). Rapid cloud genomic analysis with seamless integration into hospital workflows; ISO-certified data management, and support from bioinformatics specialists. Fast, user-friendly, and maintenance-free service. Product Description A solution…
1928 Diagnostics
Next Generation Sequencing (NGS)

CosMx Spatial Molecular Imager (SMI)

Bruker's CosMX™ Spatial Molecular Imager (SMI) is an advanced platform for in situ multi-omic spatial analysis at the single-cell level. CosMx SMI is the only in situ imaging platform that offers single-cell spatial biology of the whole transcriptome with unparalleled accuracy, sensitivity, and genomic breadth. It provides spatial multi-omics on formalin-fixed paraffin-embedded (FFPE) and fresh…
Bruker
Spatial Biology

The SeqOne Genomic Analysis Platform

SeqOne is an in vitro diagnostic platform for genetic analysis, designed to help healthcare professionals interpret next-generation sequencing (NGS) and array CGH data. The platform provides qualitative and actionable results, functioning as a clinical decision support system. Key features It is an in vitro diagnostic medical device, Class C with CE-IVD marking and certified according…
SeqOne
Next Generation Sequencing (NGS)

Devyser FH

Next-generation sequencing kit for the comprehensive analysis of genes associated with familial hypercholesterolemia, including a polygenic risk score and a SNP panel for statin response. Detailed Description Operating Principle The Devyser FH kit is an amplicon-based NGS library preparation solution with a single-tube protocol that enables targeted amplification and sample indexing within a streamlined workflow.…
Devyser
Next Generation Sequencing (NGS)